K980598 is an FDA 510(k) clearance for the EBNA-1 IGM ELISA TEST SYSTEM. Classified as Test, Antigen, Nuclear, Epstein-barr Virus (product code LLM), Class I - General Controls.
Submitted by Clark Laboratories, Inc. (Frederick, US). The FDA issued a Cleared decision on May 1, 1998 after a review of 73 days - a notably fast clearance cycle.
This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3235 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Clark Laboratories, Inc. devices